Verona Pharma PLC - ADR - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
VRNA Nasdaq 8731 https://www.veronapharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Verona Pharma PLC - ADR

Verona Pharma to Present at Jefferies Healthcare Conference - May 24th, 2023 6:00 am
Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update - May 9th, 2023 6:00 am
Verona Pharma to Present Expanded Analyses of Positive Phase 3 ENHANCE Studies in COPD in Multiple Presentations at ATS 2023 - May 2nd, 2023 6:00 am
Verona Pharma to Report First Quarter 2023 Financial Results and Provide Corporate Update - Apr 25th, 2023 6:00 am
When Will Verona Pharma plc (NASDAQ:VRNA) Breakeven? - Apr 11th, 2023 10:05 am
Nuance Pharma Announces Dosing of First Patient in ENHANCE – China Phase 3 Trial for COPD - Apr 10th, 2023 6:00 am
Verona Pharma PLC American Depositary Share (VRNA) Gains As Market Dips: What You Should Know - Apr 4th, 2023 10:15 pm
Top Healthcare Stocks for April 2023 - Mar 30th, 2023 9:22 pm
Verona Pharma PLC American Depositary Share (VRNA) Dips More Than Broader Markets: What You Should Know - Mar 28th, 2023 10:15 pm
Verona Pharma PLC American Depositary Share (VRNA) Stock Moves -0.46%: What You Should Know - Mar 22nd, 2023 10:00 pm
7 Biotech Stocks That Could Be the Next Big Thing - Mar 15th, 2023 3:44 pm
Verona Pharma PLC American Depositary Share (VRNA) Stock Sinks As Market Gains: What You Should Know - Mar 14th, 2023 10:15 pm
Verona Pharma plc (NASDAQ:VRNA) Q4 2022 Earnings Call Transcript - Mar 9th, 2023 6:59 am
Top Healthcare Stocks for March 2023 - Mar 8th, 2023 7:50 pm
Raleigh drugmaker eyes regulatory push for COPD treatment - Mar 8th, 2023 12:56 pm
Verona Pharma Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update - Mar 7th, 2023 7:00 am
Verona Pharma plc (NASDAQ:VRNA) is definitely on the radar of institutional investors who own 39% of the company - Mar 1st, 2023 10:57 am
Verona Pharma PLC American Depositary Share (VRNA) Gains But Lags Market: What You Should Know - Feb 23rd, 2023 11:00 pm
Verona Pharma to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update - Feb 21st, 2023 7:00 am
Verona (VRNA) to Report Q4 Earnings: What's in the Cards? - Feb 15th, 2023 4:49 pm